Identify companies with a strong history of sponsoring Biomedical Scientist roles in Boston.
For international STEM professionals targeting Boston's vibrant biotech scene, securing H-1B sponsorship as a Biomedical Scientist is a critical step. Get Wisa analyzes U.S. Department of Labor data to highlight companies with a proven track record of sponsoring these specialized roles in the Boston area.
| Feature | Data Point | Trend vs 2025 |
|---|---|---|
| Total H-1B Filings (Top 10 Companies) | Amazon: 55,150 Microsoft: 34,626 Google: 33,416 |
N/A (Overall counts) |
| FY2027 Lottery Selection Odds | 35.3% Overall | ↓ 27% |
| PERM Processing Time | 503 days average | N/A (Stable) |
| PWD Processing Time | 3-4 months | N/A (Stable) |
| New Form I-129 | Mandatory April 2026 | New Requirement |
| Total Verified Sponsors in Wisa | 45,000+ | N/A (Database size) |
Our analysis of DOL data reveals that while large tech companies dominate overall H-1B filings, specialized biotech hubs like Boston show a higher concentration of smaller firms with consistent sponsorship for niche roles like Biomedical Scientists. This indicates a strong demand for specialized talent beyond the major players.
When evaluating potential employers in Boston's biotech sector, look beyond just the filing volume. Check Get Wisa for companies with a high ratio of PERM filings to approvals for similar roles, as this can indicate a strong commitment to sponsoring specialized scientific talent.
The H-1B landscape in 2026 continues to be shaped by data-driven lottery selections and evolving USCIS processes. For Biomedical Scientists in Boston, understanding these trends is crucial. The FY2027 lottery saw a 27% decrease in registrations, leading to overall selection odds of 35.3%. This shift may present new opportunities for those who were selected.
New regulations in April 2026 mandate the use of Form I-129, impacting transfers and amendments. While the $100K fee is a concern for some, it strictly applies to consular processing, not change of status within the U.S. for F-1 OPT students. PERM processing averages 503 days, emphasizing the need for employers to initiate the process early.
Based on DOL data, here are examples of companies with significant H-1B filings, demonstrating their commitment to sponsoring international talent:
While these giants lead, Get Wisa's database includes thousands of smaller, specialized companies in Boston's biotech sector that actively sponsor roles like Biomedical Scientist.
Q: What are the typical salary ranges for Biomedical Scientists sponsored by H-1B in Boston?
A: Salary ranges vary significantly based on experience and employer. Our data shows top sponsors often offer competitive wages, reflecting the high cost of living and demand for specialized skills in Boston's biotech industry.
Q: How can I find smaller biotech companies in Boston that sponsor H-1B visas?
A: Get Wisa's platform allows you to filter by location and industry, revealing numerous smaller biotech firms in Boston with a history of sponsoring Biomedical Scientist roles, not just the largest corporations.
Q: Does the new Form I-129 affect H-1B sponsorship for Biomedical Scientists?
A: Yes, the mandatory use of the new Form I-129 starting April 2026 impacts all H-1B filings, including transfers and amendments for Biomedical Scientists. Employers must adapt to the updated requirements.
Q: What is the average approval rate for H-1B petitions for Biomedical Scientists in Boston?
A: Approval rates can fluctuate. While overall H-1B odds were 35.3% for FY2027, specific role and location data on Get Wisa can provide insights into historical approval trends for Biomedical Scientist positions in Boston.
Search thousands of verified H-1B sponsors by company, industry, and location.
Search H-1B Sponsors on Wisa →Salary ranges vary significantly based on experience and employer. Our data shows top sponsors often offer competitive wages, reflecting the high cost of living and demand for specialized skills in Boston's biotech industry.
Get Wisa's platform allows you to filter by location and industry, revealing numerous smaller biotech firms in Boston with a history of sponsoring Biomedical Scientist roles, not just the largest corporations.
Yes, the mandatory use of the new Form I-129 starting April 2026 impacts all H-1B filings, including transfers and amendments for Biomedical Scientists. Employers must adapt to the updated requirements.
Approval rates can fluctuate. While overall H-1B odds were 35.3% for FY2027, specific role and location data on Get Wisa can provide insights into historical approval trends for Biomedical Scientist positions in Boston.